Systemic lupus erythematosus Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1993	Psychiatric symptoms in systemic lupus erythematosus: an update.	+	-	nl	Psychosom Med 55(2):219-28 (1993)
2	1972	The study of the psychiatric symptoms of systemic lupus erythematosus.. A critical review.	+	-	nl	Psychosom Med 34(3):199-206 (1972)
3	2006	Systemic lupus erythematosus.	+	-	nl	BMJ 332(7546):890-4 (2006)
4	1995	ABC of rheumatology. Systemic lupus erythematosus and lupus-like syndromes.	+	-	nl	BMJ 310(6989):1257-61 (1995)
5	1993	Diagnosis and treatment of systemic lupus erythematosus.	+	-	nl	BMJ 307(6905):663-6 (1993)
6	1979	Systemic lupus erythematosus: treatment and prognosis.	+	-	nl	Br Med J 2(6197):1019-22 (1979)
7	1975	Editorial: Cerebral lupus.	+	-	nl	Br Med J 1(5957):537-8 (1975)
8	1973	Mortality in systemic lupus erythematosus: a 10-year review.	+	-	nl	Br Med J 4(5895):772-4 (1973)
9	2009	Usefulness of ISN/RPS classification of lupus nephritis.	+	-	nl	J Korean Med Sci 24 Suppl(-):S7-10 (2009)
10	2003	The pathogenesis of systemic lupus erythematosus.	+	-	nl	Neth J Med 61(11):343-6 (2003)
11	2003	Lupus nephritis: consequence of disturbed removal of apoptotic cells?	+	-	nl	Neth J Med 61(8):233-8 (2003)
12	2009	Lupus update: perspective and clinical pearls.	+	-	nl	Cleve Clin J Med 76(2):137-42 (2009)
13	2008	Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.	+	-	nl	Curr Cardiol Rev 4(2):116-22 (2008)
14	2006	Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.	+	-	nl	Clin Dev Immunol 13(2-4):203-8 (2006)
15	2006	The epigenetic face of systemic lupus erythematosus.	+	-	nl	J Immunol 176(12):7143-7 (2006)
16	2009	The role of extracellular DNA in autoimmunity in SLE.	+	-	nl	Scand J Immunol 70(3):175-83 (2009)
17	2006	Autoantibody determination in the diagnosis of systemic lupus erythematosus.	+	-	nl	Scand J Immunol 64(3):227-35 (2006)
18	2006	Regulatory T cells and systemic lupus erythematosus.	+	-	nl	Scand J Immunol 64(3):211-8 (2006)
19	2004	Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.	+	-	nl	Scand J Immunol 60(1-2):52-63 (2004)
20	2005	New therapies for systemic lupus erythematosus.	+	-	nl	Clin Exp Immunol 140(2):205-12 (2005)
21	1981	Current perspectives on serological reactions in SLE patients.	+	-	nl	Clin Exp Immunol 44(1):1-10 (1981)
22	2004	Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus.	+	-	nl	J Appl Genet 45(2):237-48 (2004)
23	1994	Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects.	+	-	nl	Tohoku J Exp Med 173(1):65-74 (1994)
24	1994	Nephritogenic antibodies in lupus nephritis.	+	-	nl	Tohoku J Exp Med 173(1):31-41 (1994)
25	2008	EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.	+	-	nl	Ann Rheum Dis 67(2):195-205 (2008)
26	2006	Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.	+	-	nl	Ann Rheum Dis 65(2):144-8 (2006)
27	2005	Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosus.	+	-	nl	Ann Rheum Dis 64(12):1669-70 (2005) Limburg PC
28	2005	How to monitor SLE in routine clinical practice.	+	-	nl	Ann Rheum Dis 64(4):524-7 (2005)
29	2003	Treatment of severe proliferative lupus nephritis: the current state.	+	-	nl	Ann Rheum Dis 62(9):799-804 (2003)
30	2002	Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis).	+	-	nl	Ann Rheum Dis 61(6):547-50 (2002)
31	1995	Controversies in lupus: nervous system involvement.	+	-	nl	Ann Rheum Dis 54(3):159-67 (1995)
32	1992	Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?	+	-	nl	Ann Rheum Dis 51(3):358-61 (1992)
33	2009	How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?	+	-	nl	Arthritis Res Ther 11(5):129 (2009)
34	2009	Developments in the clinical understanding of lupus.	+	-	nl	Arthritis Res Ther 11(5):245 (2009)
35	2009	Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.	+	-	nl	Arthritis Res Ther 11(3):234 (2009)
36	2008	Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.	+	-	nl	Arthritis Res Ther 10(6):229 (2008)
37	2008	Regulatory T cells in systemic lupus erythematosus: past, present and future.	+	-	nl	Arthritis Res Ther 10(6):227 (2008)
38	2008	Developments in the scientific understanding of lupus.	+	-	nl	Arthritis Res Ther 10(5):218 (2008)
39	2003	Microarray analysis of gene expression in lupus.	+	-	nl	Arthritis Res Ther 5(6):279-87 (2003)
40	2003	Systemic lupus erythematosus and the type I interferon system.	+	-	nl	Arthritis Res Ther 5(2):68-75 (2003)
41	1996	Cellular interactions in the lpr and gld models of systemic autoimmunity.	+	-	nl	Adv Dent Res 10(1):76-80 (1996)
42	2008	Lupus nephritis: the central role of nucleosomes revealed.	+	-	nl	Am J Pathol 172(2):275-83 (2008)
43	1995	Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis.	+	-	nl	Ann Intern Med 123(1):42-53 (1995)
44	1995	Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.	+	-	nl	Ann Intern Med 122(12):940-50 (1995)
45	2006	Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.	+	-	nl	Arthritis Res Ther 8(6):R182 (2006)
46	2008	Cognitive dysfunction in systemic lupus erythematosus: past, present, and future.	+	-	nl	Arthritis Rheum 58(11):3286-98 (2008)
47	2008	Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus.	+	-	nl	Arthritis Rheum 58(7):1892-9 (2008)
48	2008	Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus.	+	-	nl	Arthritis Rheum 59(3):332-7 (2008)
49	2007	Measurement of fatigue in systemic lupus erythematosus: a systematic review.	+	-	nl	Arthritis Rheum 57(8):1348-57 (2007)
50	2007	Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.	+	-	nl	Arthritis Rheum 56(7):2344-51 (2007)
51	2005	Pituitary hormones and systemic lupus erythematosus.	+	-	nl	Arthritis Rheum 52(12):3701-12 (2005)
52	2004	Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.	+	-	nl	Arthritis Rheum 50(7):2048-65 (2004)
53	2004	Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability.	+	-	nl	Arthritis Rheum 50(6):1709-20 (2004)
54	2002	Choosing treatment for proliferative lupus nephritis.	+	-	nl	Arthritis Rheum 46(8):1981-3 (2002)
55	2002	What do we know about lupus membranous nephropathy? An analytic review.	+	-	nl	Arthritis Rheum 47(4):450-5 (2002)
56	2002	Abnormal T cell signal transduction in systemic lupus erythematosus.	+	-	nl	Arthritis Rheum 46(5):1139-54 (2002)
57	1999	The key role of nucleosomes in lupus.	+	-	nl	Arthritis Rheum 42(5):833-43 (1999)
58	1999	The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.	+	-	nl	Arthritis Rheum 42(4):599-608 (1999)
59	1996	Michael Mason Prize Essay 1995. Complement, immune complexes and systemic lupus erythematosus.	+	-	nl	Br J Rheumatol 35(1):5-23 (1996)
60	2008	Pulmonary and thrombotic manifestations of systemic lupus erythematosus.	+	-	nl	Chest 133(1):271-80 (2008)
61	2000	Alveolar hemorrhage in systemic lupus erythematosus: presentation and management.	+	-	nl	Chest 118(4):1083-90 (2000)
62	2008	What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?	+	-	nl	Clin J Am Soc Nephrol 3(3):895-8 (2008)
63	2007	Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.	+	-	nl	Clin J Am Soc Nephrol 2(5):968-75 (2007) Walsh M
64	2007	Role of mycophenolate mofetil in the treatment of lupus nephritis.	+	-	nl	Clin J Am Soc Nephrol 2(5):879-82 (2007)
65	2006	New therapies for lupus nephritis.	+	-	nl	Clin J Am Soc Nephrol 1(4):863-8 (2006)
66	2004	Management of lupus nephritis: an update.	+	-	nl	J Am Soc Nephrol 15(10):2694-704 (2004)
67	1999	Lupus nephritis.	+	-	nl	J Am Soc Nephrol 10(2):413-24 (1999)
68	2003	Pathogenesis of systemic lupus erythematosus.	+	-	nl	J Clin Pathol 56(7):481-90 (2003)
69	2007	Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.	+	-	nl	Nephrol Dial Transplant 22(7):1933-42 (2007)
70	2006	Systemic lupus erythematosus.	+	-	nl	Orphanet J Rare Dis 1(-):6 (2006)
71	1993	Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).	+	-	nl	Postgrad Med J 69(814):602-8 (1993)
72	2007	Ocular manifestations of systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 46(12):1757-62 (2007)
73	2005	Complement and its breakdown products in SLE.	+	-	nl	Rheumatology (Oxford) 44(10):1227-32 (2005)
74	2005	Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus.	+	-	nl	Rheumatology (Oxford) 44(9):1086-9 (2005) Blank M
75	2002	Long-term complications of systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 41(10):1095-100 (2002)
76	2002	The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.	+	-	nl	Rheumatology (Oxford) 41(6):619-30 (2002)
77	2002	The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation.	+	-	nl	Rheumatology (Oxford) 41(6):605-18 (2002)
78	2000	Links between complement abnormalities and systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 39(2):133-41 (2000)
79	2000	Systemic lupus erythematosus-messages from experimental models.	+	-	nl	Rheumatology (Oxford) 39(1):18-27 (2000)
80	1999	A review of gastrointestinal manifestations of systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 38(10):917-32 (1999)
81	1985	Heart disease in systemic lupus erythematosus: diagnosis and management.	+	-	nl	Tex Heart Inst J 12(1):9-21 (1985)
82	2000	Pleuropulmonary manifestations of systemic lupus erythematosus.	+	-	nl	Thorax 55(2):159-66 (2000)
83	1975	Editorial: Pathogenesis of systemic lupus erythematosus.	+	-	nl	West J Med 122(2):157-8 (1975)
84	1975	Recent advances in the immunopathogenesis of systemic lupus erythematosus.	+	-	nl	West J Med 122(2):130-44 (1975)
85	2005	Acute pancreatitis as an initial symptom of systemic lupus erythematosus: a case report and review of the literature.	+	-	nl	World J Gastroenterol 11(30):4766-8 (2005)
86	1997	Lupus nephritis.	+	-	nl	Kidney Int 52(2):538-58 (1997)
87	1994	Lupus nephritis: lessons from the path lab.	+	-	nl	Kidney Int 45(3):928-38 (1994)
88	1992	Induction and progression of experimental lupus nephritis: exploration of a pathogenetic pathway.	+	-	nl	Kidney Int 41(1):5-13 (1992)
89	1986	The treatment of lupus nephritis.	+	-	nl	Kidney Int 30(5):769-87 (1986)
90	2004	Imaging findings in systemic lupus erythematosus.	+	-	nl	Radiographics 24(4):1069-86 (2004)
91	2008	The clinical importance of lymphadenopathy in systemic lupus erythematosus.	+	-	nl	Acta Reumatol Port 33(4):402-6 (2008)
92	2008	Novel therapies in lupus - focus on nephritis.	+	-	nl	Acta Reumatol Port 33(2):157-69 (2008)
93	2010	European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.	+	-	nl	Ann Rheum Dis 69(7):1269-74 (2010)
94	2011	Disturbances of apoptotic cell clearance in systemic lupus erythematosus.	+	-	nl	Arthritis Res Ther 13(1):202 (2011)
95	2011	Chromatin as a target antigen in human and murine lupus nephritis.	+	-	nl	Arthritis Res Ther 13(2):214 (2011)
96	2003	B cell abnormalities in systemic lupus erythematosus.	+	-	nl	Arthritis Res Ther 5 Suppl 4(-):S22-7 (2003)
97	2010	A new tool for detection of type I interferon activation in systemic lupus erythematosus.	+	-	nl	Arthritis Res Ther 12(4):138 (2010)
98	2010	Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.	+	-	nl	Arthritis Res Ther 12(3):210 (2010)
99	2010	The role of dendritic cells in the pathogenesis of systemic lupus erythematosus.	+	-	nl	Arthritis Res Ther 12(2):207 (2010)
100	2010	Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes).	+	-	nl	Arthritis Res Ther 12(2):111 (2010) Stohl W
101	2010	Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.	+	-	nl	Arthritis Res Ther 12(1):101 (2010)
102	2009	The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis.	+	-	nl	Arthritis Res Ther 11(6):137 (2009)
103	2009	Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.	+	-	nl	Arthritis Res Ther 11(6):255 (2009)
104	2009	TWEAK: a novel biomarker for lupus nephritis?	+	-	nl	Arthritis Res Ther 11(6):133 (2009)
105	2004	Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis.	+	-	nl	Arthritis Rheum 51(4):609-15 (2004)
106	2004	The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.	+	-	nl	Arthritis Rheum 50(11):3418-26 (2004)
107	2004	Cyclophosphamide for severe lupus nephritis: where are we now?	+	-	nl	Arthritis Rheum 50(12):3748-50 (2004)
108	2003	Sex hormones and systemic lupus erythematosus: review and meta-analysis.	+	-	nl	Arthritis Rheum 48(8):2100-10 (2003)
109	2003	Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?	+	-	nl	Arthritis Rheum 48(2):300-12 (2003)
110	2009	Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need?	+	-	nl	Arthritis Rheum 60(4):912-5 (2009)
111	2009	Systemic lupus erythematosus: a matter of life and death.	+	-	nl	Arthritis Rheum 60(6):1567-70 (2009) Pisetsky DS
112	2009	Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.	+	-	nl	Arthritis Rheum 60(11):3388-99 (2009)
113	2009	Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.	+	-	nl	Arthritis Rheum 60(9):2558-64 (2009) Suarez-Gestal M
114	2007	Systemic lupus erythematosus.	+	-	nl	BMJ 335(7626):933-6 (2007)
115	2006	Targeting of B cells in SLE: rationale and therapeutic opportunities.	+	-	nl	Bull NYU Hosp Jt Dis 64(1-2):51-6 (2006)
116	2010	Trials and tribulations in systemic lupus erythematosus.	+	-	nl	Bull NYU Hosp Jt Dis 68(3):175-8 (2010)
117	2007	B cell biology and dysfunction in SLE.	+	-	nl	Bull NYU Hosp Jt Dis 65(3):182-6 (2007)
118	2007	Biomarker discovery in human SLE nephritis.	+	-	nl	Bull NYU Hosp Jt Dis 65(3):187-93 (2007)
119	2007	Neuropsychiatric lupus: clinical and imaging aspects.	+	-	nl	Bull NYU Hosp Jt Dis 65(3):194-9 (2007)
120	2007	Cutaneous lupus: insights into pathogenesis and disease classification.	+	-	nl	Bull NYU Hosp Jt Dis 65(3):200-4 (2007)
121	2008	Lupus nephritis: histology, diagnosis, and treatment.	+	-	nl	Bull NYU Hosp Jt Dis 66(3):188-94 (2008)
122	2008	Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.	+	-	nl	Bull NYU Hosp Jt Dis 66(3):184-7 (2008)
123	2008	The genetic contribution to systemic lupus erythematosus.	+	-	nl	Bull NYU Hosp Jt Dis 66(3):176-83 (2008)
124	2010	Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment.	+	-	nl	World J Gastroenterol 16(24):2971-7 (2010)
125	2010	Updates on the treatment of lupus nephritis.	+	-	nl	J Am Soc Nephrol 21(12):2028-35 (2010)
126	2004	Reclassification of lupus glomerulonephritis: back to the future.	+	-	nl	J Am Soc Nephrol 15(2):501-3 (2004) Glassock RJ
127	2009	Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.	+	-	nl	J Am Soc Nephrol 20(4):696-704 (2009)
128	2004	Distinguishing C1q nephropathy from lupus nephritis.	+	-	nl	Nephrol Dial Transplant 19(6):1420-6 (2004)
129	2004	Deranged removal of apoptotic cells: its role in the genesis of lupus.	+	-	nl	Nephrol Dial Transplant 19(2):282-5 (2004)
130	2009	How did cyclophosphamide become the drug of choice for lupus nephritis?	+	-	nl	Nephrol Dial Transplant 24(2):381-4 (2009)
131	2006	Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century.	+	-	nl	Nephrol Dial Transplant 21(6):1739 (2006)
132	2011	The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2011(-):207504 (2011)
133	2011	Murine models of systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2011(-):271694 (2011)
134	2010	Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.	+	-	nl	J Biomed Biotechnol 2010(-):686480 (2010)
135	2010	Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):294582 (2010)
136	2010	Interferon alpha in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):948364 (2010)
137	2010	Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):457146 (2010)
138	2010	Anti-TNF-alpha therapies in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):465898 (2010)
139	2010	Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):268436 (2010)
140	2010	Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.	+	-	nl	J Biomed Biotechnol 2010(-):365083 (2010)
141	2010	Cytokine networks in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):676284 (2010)
142	2010	Biomarkers for lupus nephritis: a critical appraisal.	+	-	nl	J Biomed Biotechnol 2010(-):638413 (2010)
143	2010	IL-17 in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):943254 (2010)
144	2010	Cytokines in systemic lupus erythematosus.	+	-	nl	J Biomed Biotechnol 2010(-):735169 (2010)
145	2010	Genetics of systemic lupus erythematosus: contributions of mouse models in the era of human genome-wide association studies.	+	-	nl	Discov Med 10(50):71-8 (2010)
146	2011	Treating lupus in the kidney: where are we now, and where are we going?	+	-	nl	Discov Med 12(65):341-9 (2011)
147	2010	Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?	+	-	nl	Discov Med 10(54):416-24 (2010)
148	2010	mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?	+	-	nl	Discov Med 9(46):173-8 (2010)
149	2010	Biologic therapy for systemic lupus erythematosus.	+	-	nl	Discov Med 9(44):20-3 (2010)
150	2009	The busy life of regulatory T cells in systemic lupus erythematosus.	+	-	nl	Discov Med 8(40):13-7 (2009)
151	2010	IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.	+	-	nl	PLoS One 5(8):e12280 (2010)
152	2010	The role of B cells in lupus pathogenesis.	+	-	nl	Int J Biochem Cell Biol 42(4):543-50 (2010)
153	2005	Cellular and molecular mechanisms of regulation of autoantibody production in lupus.	+	-	nl	Ann N Y Acad Sci 1051(-):433-41 (2005)
154	2008	Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease.	+	-	nl	Rheumatology (Oxford) 47(10):1498-502 (2008)
155	2004	Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.	+	-	nl	Rheumatology (Oxford) 43(1):7-12 (2004)
156	2003	Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 42(2):214-22 (2003)
157	2009	Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!	+	-	nl	Rheumatology (Oxford) 48(4):332-41 (2009)
158	2008	Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.	+	-	nl	Rheumatology (Oxford) 47(3):256-62 (2008)
159	2008	Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.	+	-	nl	Rheumatology (Oxford) 47(9):1367-72 (2008)
160	2008	Challenges of lupus pregnancies.	+	-	nl	Rheumatology (Oxford) 47 Suppl 3(-):iii9-12 (2008)
161	2006	Moderate and severe neutropenia in patients with systemic lupus erythematosus.	+	-	nl	Rheumatology (Oxford) 45(8):994-8 (2006)
162	2009	Osteoporosis in patients with systemic lupus erythematosus.	+	-	nl	Isr Med Assoc J 11(8):486-91 (2009)
163	2008	A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.	+	-	nl	Isr Med Assoc J 10(1):40-2 (2008)
164	2008	The story of the 16/6 idiotype and systemic lupus erythematosus.	+	-	nl	Isr Med Assoc J 10(1):37-9 (2008)
165	2008	Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.	+	-	nl	Intern Med 47(9):867-75 (2008)
166	2004	Conference report--lupus nephritis: diagnosis, therapy, and outcomes.	+	-	nl	MedGenMed 6(3):23 (2004)
167	2010	Lupus band test.	+	-	nl	Indian J Dermatol Venereol Leprol 76(3):298-300 (2010)
168	2010	Review article: systemic lupus erythematosus: a review for anesthesiologists.	+	-	nl	Anesth Analg 111(3):665-76 (2010)
169	2003	Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.	+	-	nl	Clin Exp Immunol 131(3):396-7 (2003)
170	2009	Interleukin-17 and systemic lupus erythematosus: current concepts.	+	-	nl	Clin Exp Immunol 157(2):209-15 (2009)
171	2012	Imaging assessment of cardiovascular disease in systemic lupus erythematosus.	+	-	nl	Clin Dev Immunol 2012(-):694143 (2012)
172	2012	RP105-negative B cells in systemic lupus erythematosus.	+	-	nl	Clin Dev Immunol 2012(-):259186 (2012)
173	2010	Targeting Toll-like receptors for treatment of SLE.	+	-	nl	Mediators Inflamm 2010(-):- (2010)
174	2004	Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus.	+	-	nl	J Rheumatol 31(3):419-21 (2004)
175	2004	The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?	+	-	nl	J Rheumatol 31(11):2093-8 (2004)
176	2007	Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information?	+	-	nl	J Rheumatol 34(2):256-8 (2007) Oates J
177	2006	Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure.	+	-	nl	J Rheumatol 33(8):1464-6 (2006)
178	2009	Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.	+	-	nl	Hum Mol Genet 18(R2):R130-6 (2009)
179	2009	Pancreatitis and systemic lupus erythematosus.	+	-	nl	Rev Esp Enferm Dig 101(8):571-9 (2009)
180	2011	HDAC inhibition in lupus models.	+	-	nl	Mol Med 17(5-6):417-25 (2011)
181	2009	Biomarkers for lupus nephritis: the quest continues.	+	-	nl	Clin J Am Soc Nephrol 4(11):1858-65 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.